LeonaBio (LONA) Change in Acquisitions & Divestments (2019 - 2026)
LeonaBio (LONA) reported Change in Acquisitions & Divestments of $5.1 million for Q1 2026, up 78.07% year-over-year from $2.8 million in Q1 2025, and up 49.26% quarter-over-quarter from $3.4 million in Q4 2025.
LeonaBio (LONA) Change in Acquisitions & Divestments (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $5.1 million in Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $5.1 million, up 78.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.0 million (down 54.67% YoY), and the FY2025 annual result was $21.7 million, down 68.48% from the prior year.
- Change in Acquisitions & Divestments advanced to $5.1 million in Q1 2026 per LONA's latest filing, from $3.4 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $47.7 million in Q2 2023 and troughed at $2.8 million in Q1 2025.
- A 5-year average of $23.3 million and a median of $21.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments surged 116.71% in 2022, then plunged 84.97% in 2025.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $34.8 million in 2022, then plunged by 81.65% to $6.4 million in 2023, then jumped by 182.26% to $18.0 million in 2024, then slumped by 81.15% to $3.4 million in 2025, then soared by 49.26% to $5.1 million in 2026.
- Business Quant data shows LONA's Change in Acquisitions & Divestments at $5.1 million in Q1 2026, $3.4 million in Q4 2025, and $9.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.08 Mn |
| Mar 31, 2026 | 5.08 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Jun 30, 2025 | 6.51 Mn |
| Jun 30, 2025 | 6.51 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Sep 30, 2024 | 18.04 Mn |
| Sep 30, 2024 | 18.04 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Mar 31, 2024 | 18.96 Mn |
| Mar 31, 2024 | 18.96 Mn |
| Dec 31, 2023 | 6.39 Mn |
| Dec 31, 2023 | 6.39 Mn |
| Sep 30, 2023 | 23.50 Mn |
| Sep 30, 2023 | 23.50 Mn |